A detailed history of Caxton Associates LP transactions in Collegium Pharmaceutical, Inc stock. As of the latest transaction made, Caxton Associates LP holds 79,344 shares of COLL stock, worth $2.31 Million. This represents 0.12% of its overall portfolio holdings.

Number of Shares
79,344
Previous 53,611 48.0%
Holding current value
$2.31 Million
Previous $1.73 Million 77.58%
% of portfolio
0.12%
Previous 0.06%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$31.4 - $39.07 $808,016 - $1.01 Million
25,733 Added 48.0%
79,344 $3.07 Million
Q2 2024

Aug 14, 2024

BUY
$31.36 - $39.99 $283,682 - $361,749
9,046 Added 20.3%
53,611 $1.73 Million
Q1 2024

May 15, 2024

BUY
$31.23 - $40.91 $1.39 Million - $1.82 Million
44,565 New
44,565 $1.73 Million

Others Institutions Holding COLL

About COLLEGIUM PHARMACEUTICAL, INC


  • Ticker COLL
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 34,126,200
  • Market Cap $995M
  • Description
  • Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, develops and commercializes medicines for pain management. Its portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; Nucynta ER and Nucynta IR, which are extended-release and immediate-release formulations of tapentadol; and Xtampza ...
More about COLL
Track This Portfolio

Track Caxton Associates LP Portfolio

Follow Caxton Associates LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Caxton Associates LP, based on Form 13F filings with the SEC.

News

Stay updated on Caxton Associates LP with notifications on news.